Fundz

Eidos Therapeutics, Inc. reported raising $26 Million in an initial SEC Form D filing, from an offering of $74 Million

PRIVATEApr 12, 2018$26M of $74M raised

Amount Raised

$26 Million

$26 Million sold, per SEC Form D (first sale Apr 12, 2018)

Round Type

Venture

San FranciscoBiotechnology

Quick answer

Eidos Therapeutics, Inc. raised $26 Million in a funding round, dated April 12, 2018. Eidos Therapeutics, Inc. is based in San Francisco, California, United States.

How much did Eidos Therapeutics, Inc. raise?
Eidos Therapeutics, Inc. raised $26 Million in a funding round on April 12, 2018.
What does Eidos Therapeutics, Inc. do?
Targeting TTR amyloidosis at its source.
Where is Eidos Therapeutics, Inc. based and how big is it?
Eidos Therapeutics, Inc. is based in San Francisco, California, United States.

Source: Fundz verified event record.

Who else raised in Biotechnology around the same time

Companies in the same sectors as Eidos Therapeutics, Inc. that raised within 45 days of this round, from Fundz verified event records.

  • Shattuck Labs, Inc. raised $47M on May 25, 2018.
  • HeMemics Biotechnologies, Inc. raised $777K (Seed) on May 25, 2018.
  • Acasti raised $373K on May 25, 2018.
  • USBC raised $138K on May 25, 2018.
  • Niki BioSolutions, Inc. raised $1.6M (Seed) on May 25, 2018.
  • Grail raised $300M on May 25, 2018.

Who to call at Eidos Therapeutics, Inc., and when

A new round usually means Eidos Therapeutics, Inc. is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Eidos Therapeutics, Inc. raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Eidos Therapeutics, Inc., from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Eidos Therapeutics, Inc.. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Eidos Therapeutics, Inc.

Location

101 MONTGOMERY STREET, SUITE 2550

San Francisco, California, United States

About

Targeting TTR amyloidosis at its source. Transthyretin (TTR) amyloidosis is a family of rare, devastating diseases with serious unmet medical needs.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Eidos Therapeutics, Inc. raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Predictive Intelligence
Strategic

ML-powered predictions for Eidos Therapeutics, Inc.'s next move

See what Strategic adds

Eidos Therapeutics, Inc. raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.